In this study, we identified several genetic variants within the TNF/TRAF2/ASK1/p38 kinase pathway that mediated risk of developing these adverse events, which not only provide potential biomarkers for prediction, but also implicates this key inflammatory and stress signaling pathway as playing a role in the physiological response to lobectomy in lung cancer patients. The gene discussed is TNF; the disease is lung carcinoma.